Table 2. Analysis of the difference between final height and predicted target heights assessed by three different methods.
|
- |
Target height |
Final height |
p value* |
|
Target height-Final height |
Target height-Final height |
||
|
BP predicted adult height at treatment initiation |
163.2±6.4 |
163.0±6.4 |
0.861 |
|
RWT predicted adult height at treatment initiation |
164.1±4.9 |
163.0±6.4 |
0.250 |
|
BAPCPHE predicted adult height at treatment initiation |
163.1±5.6 |
163.0±6.4 |
0.948 |
|
BP predicted adult height at the end of the 1st year of treatment |
164.0±6.2 |
163.0±6.4 |
0.297 |
|
RWT predicted adult height at the end of the 1st year of treatment |
163.3±4.4 |
163.0±6.4 |
0.776 |
|
BAPCPHE predicted adult height at the end of 1st year of treatment |
163.4±6.0 |
163.0±6.4 |
0.694 |
|
BP predicted adult height at the end of the 2nd year of treatment |
165.6±7.4 |
163.0±6.4 |
0.007 |
|
RWT predicted adult height at the end of the 2nd year of treatment |
163.0±4.9 |
163.0±6.4 |
0.965 |
|
BAPCPHE predicted adult height at the end of 2nd year of treatment |
164.2±6.4 |
163.0±6.4 |
0.208 |
|
BP predicted adult height at the end of the 3rd year of treatment |
165.0±5.1 |
163.0±6.4 |
0.036 |
|
RWT predicted adult height at the end of the 3rd year of treatment |
163.0±2.8 |
163.0±6.4 |
0.965 |
|
BAPCPHE predicted adult height at the end of 3rd year of treatment |
164.3±4.2 |
163.0±6.4 |
0.172 |
|
BP predicted adult height at the end of treatment |
165.8±6.1 |
163.0±6.4 |
0.004 |
|
RWT predicted adult height at the end of treatment |
162.9±4.4 |
163.0±6.4 |
0.878 |
|
BAPCPHE predicted adult height at the end of treatment |
164.4±4.9 |
163.0±6.4 |
0.141 |
*p<0.005 is considered statistically significant.
BP: Bayley-Pinneau method, RWT: Roche-Wainer-Thissen method, BAPCPHE: Bone Age Percentile Curve Projected Height Estimation